<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03186144</url>
  </required_header>
  <id_info>
    <org_study_id>CHARGE</org_study_id>
    <nct_id>NCT03186144</nct_id>
  </id_info>
  <brief_title>Clinical and Molecular Study of CHARGE Syndrom</brief_title>
  <acronym>CHARGE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <brief_summary>
    <textblock>
      1. Clinical description of a French cohort of patients with CHARGE syndrome.

        2. Search any phenotype-genotype correlation in typical, atypical or incomplete form of the
           syndrome

        3. Using Next generation Sequencing, try to identify other genes involved in this syndrome,
           as the CHD7 gene is involved in only 40-60% of cases
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Description Clinical and molecular analysis of a French cohort CHARGE</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Execution of the socio-adaptive scale, parental scale</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of mutations of CHD7 and / or type of mutations</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>analysis CHD7 gene from the patient's DNA</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">141</enrollment>
  <condition>Development Abnormalies</condition>
  <condition>Inclusion on Clinical Criteria of the Syndrome</condition>
  <arm_group>
    <arm_group_label>No arm : descriptive study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Blodd punction for genetic analysis</intervention_name>
    <arm_group_label>No arm : descriptive study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Clinical criteria

        Major criteria:

          -  Ocular coloboma

          -  Chonamal atresia and/or cleft palate

          -  Semi-CircularCanals hypoplasia

        Minor criteria:

          -  Cranial nerves

          -  Hypothalamic-pituitary deficiency

          -  Internal or external ear malformation

          -  Cardiac, esophageal malformations

          -  Intellectual Deficiency

        Diagnosis criteria:

          -  Typical CHARGE: 3 major criteria or 2 major + 2 minor

          -  Partial CHARGE: 2 major + 1 minor

          -  Atypical CHARGE: 2 major without minor or 1 major + 2 minor

        Exclusion Criteria:

          -  Absent consentment for genetic analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>French Referent centers for developement abnomalies</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2017</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

